DeepMed Research

Shiraz University of Medical Sciences

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1946-01-01

Employees: 10K

Market Cap: -

Website: http://www.gsia.sums.ac.ir

Clinical Trials

Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysis

Phase 4

Completed

Conditions: Anemia

Interventions: Drug: placebo
Drug: vitamin c

First Posted Date: 2016-05-23

Last Posted Date: 2016-05-23

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 66

Registration Number: NCT02780505

The Effects of Rhus Coriaria L. on Body Weight

Not Applicable

Completed

Conditions: Body Weight

Interventions: Drug: Placebo
Drug: Rhus Coriaria L.(Rhus)

First Posted Date: 2016-04-28

Last Posted Date: 2018-08-23

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 50

Registration Number: NCT02754089

Locations: 🇮🇷
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of

Resveratrol's Effects in Diabetic Nephropathy

Early Phase 1

Completed

Conditions: Diabetic Nephropathy

Interventions: Drug: Placebo
Drug: Resveratrol
Drug: Losartan

First Posted Date: 2016-03-10

Last Posted Date: 2017-10-05

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT02704494

Locations: 🇮🇷
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of

Melatonin's Effects on Treatment Of Diabetes Mellitus

Early Phase 1

Conditions: Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Melatonin

First Posted Date: 2016-02-25

Last Posted Date: 2019-04-08

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT02691897

Locations: 🇮🇷
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of

Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

Early Phase 1

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Cyproterone compound + Spironolactone
Drug: Metformin
Drug: Pioglitazone

First Posted Date: 2016-02-24

Last Posted Date: 2019-11-12

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT02689843

Locations: 🇮🇷
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of

Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus

Phase 2

Completed

Conditions: Pruritus
End-Stage Renal Disease

Interventions: Drug: Wheat
Drug: Fumaria

First Posted Date: 2016-02-02

Last Posted Date: 2016-02-02

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 63

Registration Number: NCT02671162

Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI

Phase 4

Completed

Conditions: Pregnancy

Interventions: Drug: LH
Drug: HCG
Drug: Clomiphene

First Posted Date: 2015-12-23

Last Posted Date: 2015-12-23

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 86

Registration Number: NCT02638285

Locations: 🇮🇷
Health Policy Research Center, Shiraz, Fars, Iran, Islamic Republic of

Transdermal Nitroglycerin and Nifedipine in Preterm Labor

Phase 4

Completed

Conditions: Managing Preterm Labor

Interventions: Drug: Transdermal nitroglycerin
Drug: nifedipine

First Posted Date: 2015-10-22

Last Posted Date: 2015-10-22

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 112

Registration Number: NCT02583633

Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial

Phase 2

Completed

Conditions: Depression
Anxiety

Interventions: Drug: Nepeta menthoides Boiss & Bohse freeze dried extract
Drug: Sertraline

First Posted Date: 2015-10-01

Last Posted Date: 2015-10-01

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT02565316

Montelukast for Treatment of Uremic Pruritus

Not Applicable

Completed

Conditions: Renal Insufficiency, Chronic

Interventions: Drug: Montelukast
Drug: placebo

First Posted Date: 2015-09-24

Last Posted Date: 2015-09-24

Lead Sponsor: Shiraz University of Medical Sciences

Target Recruit Count: 73

Registration Number: NCT02559388

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy